TREATMENT OF HEPATITIS C VIRUS INFECTIONS WITH TELAPREVIR (VX-950) IN PATIENTS NON-RESPONSIVE TO TREATMENT WITH PEGYLATED INTERFER0N-ALPHA-2A/2B AND RIBAVIRIN

• 收藏
• 分享

专利权人:

VERTEX PHARMACEUTICALS INCORPORATED

发明人:

MCNAIR, LINDSAY,MCHUTCHISON, JOHN

申请号：

NZ58865509

公开号：

NZ588655A

申请日:

2009.04.23

申请国别(地区):

NZ

年份:

2012

代理人:

摘要：

Disclosed herein is the use of VX-950 or a pharmaceutically acceptable salt thereof in an amount of about 750 mg or in an amount of about 1125 mg for the manufacture of a medicament for co-administration with pegylated interferon and ribavirin to a P/R non-responsive patient infected with Hepatitis C virus.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/